Top compounds associated with response to IGFALS


Feature Type Standardized
Nominal ANOVA
mRNA staurosporine CTRPv2 pan-cancer AAC -0.06 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA regorafenib CTRPv2 pan-cancer AAC -0.03 0.4
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA STF-31 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC 0.028 0.4
Download CSV